Affordable Access

deepdyve-link
Publisher Website

An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients.

Authors
  • Rutherford, Elaine1, 2
  • Stewart, Graham3
  • Houston, J Graeme4
  • Jardine, Alan G1, 2
  • Mark, Patrick B1, 2
  • Struthers, Allan D4
  • 1 Institute of Cardiovascular & Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • 2 Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK.
  • 3 Renal Unit, Ninewells Hospital & Medical School, Dundee, UK.
  • 4 Division of Molecular & Clinical Medicine, School of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
Type
Published Article
Journal
Journal of clinical pharmacology
Publication Date
Nov 01, 2017
Volume
57
Issue
11
Pages
1409–1414
Identifiers
DOI: 10.1002/jcph.939
PMID: 28597919
Source
Medline
Keywords
License
Unknown
Report this publication

Statistics

Seen <100 times